Cancer Clinical Trials in Los Angeles, California
7 recruitingLos Angeles, California
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
BreastCancerMetastatic+2 more
University of Southern California65 enrolled3 locationsNCT04333706
Recruiting
Phase 1
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Breast CancerEndometrial CancerAdvanced Solid Tumor+2 more
Alterome Therapeutics, Inc.110 enrolled51 locationsNCT06533059
Recruiting
Phase 1
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Tizona Therapeutics, Inc240 enrolled41 locationsNCT04485013
Recruiting
Phase 1
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Breast CancerProstate CancerMetastatic Solid Tumor+3 more
Angiex, Inc.80 enrolled6 locationsNCT06440005
Recruiting
Not Applicable
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
CancerEnd of Life
Stanford University2,996 enrolled17 locationsNCT05297734
Recruiting
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Cancer
MiraKind15,000 enrolled1 locationNCT02253251
Recruiting
Phase 1
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
CancerCancer, Lung
Conjupro Biotherapeutics, Inc.102 enrolled13 locationsNCT05948865